Strengthening IPC Regulations and Antibiotic Surveillance through Post-Acute Analytics

Some 40-75% of prescribed antibiotics in SNFs may be unnecessary or inappropriate, causing risk of serious infections, increased adverse drug events and drug interactions, and even death. There’s also the threat of antibiotic-resistant infections, which afflict 2.8 million Americans annually. We know that monitoring and tracking antibiotic use is an arduous and time consuming process, but vital if we want to improve outcomes and eliminate needless side effects. The right technology can help by identifying the early warning signs of infection and highlighting the need for possible testing to determine the appropriate drug interventions. Operators can also leverage live data analysis to meet state and federal requirements, prepare for regulatory reporting and onsite surveys, and conduct infection surveillance.

Speaker: Cheryl Scalzo, RN, Clinical Account Manager, Real Time Medical Systems

This session is hosted by LifeSpan Network and will be presented at the 2022 Annual Conference & Expo.